<SEC-DOCUMENT>0001193125-26-112753-index.html : 20260318
<SEC-HEADER>0001193125-26-112753.hdr.sgml : 20260318
<ACCEPTANCE-DATETIME>20260318091456
ACCESSION NUMBER:		0001193125-26-112753
CONFORMED SUBMISSION TYPE:	15-12G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260318
DATE AS OF CHANGE:		20260318
EFFECTIVENESS DATE:		20260318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RAPT Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001673772
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				473313701
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		15-12G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38997
		FILM NUMBER:		26766077

	BUSINESS ADDRESS:	
		STREET 1:		561 ECCLES AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 489-9000

	MAIL ADDRESS:	
		STREET 1:		561 ECCLES AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FLX Bio, Inc.
		DATE OF NAME CHANGE:	20160504
</SEC-HEADER>
<DOCUMENT>
<TYPE>15-12G
<SEQUENCE>1
<FILENAME>d77910d1512g.htm
<DESCRIPTION>15-12G
<TEXT>
Document 1 - file: d77910d1512g.htm

</DOCUMENT>
</SEC-DOCUMENT>